rs537602741

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001100878.2(MROH6):​c.2095G>T​(p.Asp699Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,221,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000079 ( 0 hom. )

Consequence

MROH6
NM_001100878.2 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.743

Publications

0 publications found
Variant links:
Genes affected
MROH6 (HGNC:27814): (maestro heat like repeat family member 6)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05454147).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MROH6NM_001100878.2 linkc.2095G>T p.Asp699Tyr missense_variant Exon 14 of 14 ENST00000398882.8 NP_001094348.1 A6NGR9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MROH6ENST00000398882.8 linkc.2095G>T p.Asp699Tyr missense_variant Exon 14 of 14 5 NM_001100878.2 ENSP00000381857.3 A6NGR9

Frequencies

GnomAD3 genomes
AF:
0.000475
AC:
72
AN:
151690
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00167
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000959
GnomAD4 exome
AF:
0.0000795
AC:
85
AN:
1069324
Hom.:
0
Cov.:
31
AF XY:
0.0000733
AC XY:
37
AN XY:
504858
show subpopulations
African (AFR)
AF:
0.00169
AC:
38
AN:
22444
American (AMR)
AF:
0.00
AC:
0
AN:
8042
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13772
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
19538
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2846
European-Non Finnish (NFE)
AF:
0.0000460
AC:
42
AN:
913252
Other (OTH)
AF:
0.000117
AC:
5
AN:
42762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000474
AC:
72
AN:
151798
Hom.:
0
Cov.:
32
AF XY:
0.000472
AC XY:
35
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.00166
AC:
69
AN:
41446
American (AMR)
AF:
0.0000656
AC:
1
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67836
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000495

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 16, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2095G>T (p.D699Y) alteration is located in exon 14 (coding exon 14) of the MROH6 gene. This alteration results from a G to T substitution at nucleotide position 2095, causing the aspartic acid (D) at amino acid position 699 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
19
DANN
Benign
0.95
DEOGEN2
Benign
0.0075
T;.;.;.
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.51
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.53
.;.;.;T
M_CAP
Uncertain
0.085
D
MetaRNN
Benign
0.055
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L;.;.;.
PhyloP100
0.74
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-1.8
N;D;D;D
REVEL
Benign
0.084
Sift
Uncertain
0.0040
D;D;D;D
Sift4G
Uncertain
0.017
D;D;D;D
Polyphen
0.95
P;.;.;.
Vest4
0.26
MVP
0.12
MPC
0.13
ClinPred
0.68
D
GERP RS
3.2
Varity_R
0.12
gMVP
0.38
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs537602741; hg19: chr8-144649474; API